FDA Inspection 1166827 — Angelini Pharma Italia Aziendi Chimiche Riunite SPA
The FDA completed an inspection of Angelini Pharma Italia Aziendi Chimiche Riunite SPA on June 25, 2021 in Aprilia. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 25, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Aprilia (Italy)
Additional Details
Mutual Recognition Agreement (MRA)